BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JM, Jung HC. Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea. Helicobacter 2013;18:135-42. [PMID: 23066652 DOI: 10.1111/hel.12018] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
Number Citing Articles
1 Noh CK, Lee E, Park B, Lim SG, Shin SJ, Lee KM, Lee GH. Effect of Helicobacter pylori Eradication Treatment on Metachronous Gastric Neoplasm Prevention Following Endoscopic Submucosal Dissection for Gastric Adenoma. J Clin Med 2023;12. [PMID: 36836045 DOI: 10.3390/jcm12041512] [Reference Citation Analysis]
2 Ding SZ, Du YQ, Lu H, Wang WH, Cheng H, Chen SY, Chen MH, Chen WC, Chen Y, Fang JY, Gao HJ, Guo MZ, Han Y, Hou XH, Hu FL, Jiang B, Jiang HX, Lan CH, Li JN, Li Y, Li YQ, Liu J, Li YM, Lyu B, Lu YY, Miao YL, Nie YZ, Qian JM, Sheng JQ, Tang CW, Wang F, Wang HH, Wang JB, Wang JT, Wang JP, Wang XH, Wu KC, Xia XZ, Xie WF, Xie Y, Xu JM, Yang CQ, Yang GB, Yuan Y, Zeng ZR, Zhang BY, Zhang GY, Zhang GX, Zhang JZ, Zhang ZY, Zheng PY, Zhu Y, Zuo XL, Zhou LY, Lyu NH, Yang YS, Li ZS; National Clinical Research Center for Digestive Diseases (Shanghai), Gastrointestinal Early Cancer Prevention & Treatment Alliance of China (GECA), Helicobacter pylori Study Group of Chinese Society of Gastroenterology, and Chinese Alliance for Helicobacter pylori Study. Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition). Gut 2022;71:238-53. [PMID: 34836916 DOI: 10.1136/gutjnl-2021-325630] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 20.0] [Reference Citation Analysis]
3 Kim N. Helicobacter pylori Infection and Gastritis. Sex/Gender-Specific Medicine in the Gastrointestinal Diseases 2022. [DOI: 10.1007/978-981-19-0120-1_8] [Reference Citation Analysis]
4 Tryapyshko AA, Dekhnich NN. Paradigm shift in the management of patients with <i>H. pylori</i> infection. jour 2021. [DOI: 10.31146/1682-8658-ecg-193-9-109-113] [Reference Citation Analysis]
5 Erkut M, Uzun DY, Kaklıkkaya N, Fidan S, Yoğun Y, Coşar AM, Akyıldız E, Topbaş M, Özgür O, Arslan M. Sociodemographic characteristics and clinical risk factors of Helicobacter pylori infection and antibiotic resistance in the Eastern Black Sea region of Turkey. Turk J Gastroenterol 2020;31:221-33. [PMID: 32343234 DOI: 10.5152/tjg.2020.18631] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Zhao JB, Yuan L, Yu XC, Shao QQ, Ma J, Yu M, Wu Y, Qi YB, Hu RB, Wei PR, Jia BL, Zhang LZ, Zhang YR, Ding SZ. Whole family-based Helicobacter pylori eradication is a superior strategy to single-infected patient treatment approach: A systematic review and meta-analysis. Helicobacter 2021;26:e12793. [PMID: 33675089 DOI: 10.1111/hel.12793] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Lazebnik LB, Bordin DS, Dekhnich NN, Kozlov RS, Livzan MA, Lyalukova EA, Luzina EV, Belova GV, Abdulkhakov RA, Abdulkhakov SR. The need to strengthen measures for the diagnosis and treatment of Helicobacter pylori infection in Russia. Memorandum. jour 2021. [DOI: 10.31146/1682-8658-ecg-187-3-83-96] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Park JS, Jun JS, Seo JH, Youn HS, Rhee KH. Changing prevalence of Helicobacter pylori infection in children and adolescents. Clin Exp Pediatr 2021;64:21-5. [PMID: 32668822 DOI: 10.3345/cep.2019.01543] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
9 Kato S, Shimizu T, Toyoda S, Gold BD, Ida S, Ishige T, Fujimura S, Kamiya S, Konno M, Kuwabara K, Ushijima K, Yoshimura N, Nakayama Y; Japanese Society for Pediatric Gastroenterology, Hepatology and Nutrition. The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood. Pediatr Int 2020;62:1315-31. [PMID: 32657507 DOI: 10.1111/ped.14388] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
10 Zhang Y, Dong Q, Tian L, Zhang S, Zuo N, Zhang S, Ding Z. Risk factors for recurrence of Helicobacter pylori infection after successful eradication in Chinese children: A prospective, nested case-control study. Helicobacter 2020;25:e12749. [PMID: 32770644 DOI: 10.1111/hel.12749] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ding SZ. Global whole family based-Helicobacter pylori eradication strategy to prevent its related diseases and gastric cancer. World J Gastroenterol 2020; 26(10): 995-1004 [PMID: 32205991 DOI: 10.3748/wjg.v26.i10.995] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
12 Xie Y, Song C, Cheng H, Xu C, Zhang Z, Wang J, Huo L, Du Q, Xu J, Chen Y, Zhang X, Zhang G, Yang G, Zuo X, Guo T, Lu Y, Wang F, Wang X, Zhuang K, Chen S, Liu W, Lu N; Chinese Society of Gastroenterology, Chinese Study Group on Helicobacter pylori and Peptic Ulcer. Long-term follow-up of Helicobacter pylori reinfection and its risk factors after initial eradication: a large-scale multicentre, prospective open cohort, observational study. Emerg Microbes Infect 2020;9:548-57. [PMID: 32160805 DOI: 10.1080/22221751.2020.1737579] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
13 Choi YK, Ahn JY, Won SH, Jung K, Na HK, Jung KW, Kim DH, Lee JH, Choi KD, Song HJ, Lee GH, Jung HY. Eradication rate of Helicobacter pylori reinfection in Korea: A retrospective study. J Gastroenterol Hepatol 2019;34:1696-702. [PMID: 30811663 DOI: 10.1111/jgh.14639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
14 Ikezawa K, Kanamori T, Iwai K, Otsuka K, Kobayashi M, Ochi D, Sugiyama H, Suzuki H, Soeda A. Helicobacter pylori infection in rehabilitation staff younger than 35 years: Infection surveillance for three years. Journal of Infection Prevention 2019;20:240-245. [DOI: 10.1177/1757177419852669] [Reference Citation Analysis]
15 Nam JH, Ryu KH, Park BJ, Lee CW, Park EC. Rate and predictive factors of Helicobacter pylori recurrence: Analysis of a screening cohort. Saudi J Gastroenterol 2019;25:251-6. [PMID: 30950407 DOI: 10.4103/sjg.SJG_456_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Lee MW, Kim GH, Han SY, Park YJ, Jeon HK, Lee BE, Song GA. First-lineHelicobacter pyloriEradication with Standard Triple Therapy and Concomitant Therapy: A Retrospective Study. Korean J Helicobacter Up Gastrointest Res 2018;18:120. [DOI: 10.7704/kjhugr.2018.18.2.120] [Reference Citation Analysis]
17 Tolouie H, Mohammadifar MA, Ghomi H, Hashemi M. Cold atmospheric plasma manipulation of proteins in food systems. Crit Rev Food Sci Nutr 2018;58:2583-97. [PMID: 28613926 DOI: 10.1080/10408398.2017.1335689] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
18 Jeon J, Kim JK, Kim G. Detection of Clarithromycin-Resistant Helicobacter pylori by Polymerase Chain Reaction Using Residual Samples from Rapid Urease Test. Indian Journal of Medical Microbiology 2017;35:406-409. [DOI: 10.4103/ijmm.ijmm_17_246] [Reference Citation Analysis]
19 Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance. Front Cell Infect Microbiol 2017;7:168. [PMID: 28529929 DOI: 10.3389/fcimb.2017.00168] [Cited by in Crossref: 68] [Cited by in F6Publishing: 75] [Article Influence: 11.3] [Reference Citation Analysis]
20 Vilaichone RK, Wongcha Um A, Chotivitayatarakorn P. Low Re-infection Rate of Helicobacter pylori after Successful Eradication in Thailand: A 2 Years Study. Asian Pac J Cancer Prev 2017;18:695-7. [PMID: 28440977 DOI: 10.22034/APJCP.2017.18.3.695] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
21 Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Kim HK, Lee YD. Second-line bismuth-containing quadruple therapy for Helicobacter pylori eradication and impact of diabetes. World J Gastroenterol 2017; 23(6): 1059-1066 [PMID: 28246480 DOI: 10.3748/wjg.v23.i6.1059] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
22 Zhou LY, Song ZQ, Xue Y, Li X, Li YQ, Qian JM. Recurrence of Helicobacter pylori infection and the affecting factors: A follow-up study. J Dig Dis 2017;18:47-55. [PMID: 28026906 DOI: 10.1111/1751-2980.12440] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
23 Kim BJ, Kim HS, Song HJ, Chung IK, Kim GH, Kim BW, Shim KN, Jeon SW, Jung YJ, Yang CH, Kim JH, Kim TH, Kim SG, Shin WG, Kim SM, Han SW, Lee JH, Kim KH, Park SK, Park BJ, Lee J, Kim JG; Korean College of Helicobacter and Upper Gastrointestinal Research. Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis. J Korean Med Sci 2016;31:1246-53. [PMID: 27478335 DOI: 10.3346/jkms.2016.31.8.1246] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
24 Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. Postgrad Med J. 2016; May 24. [Epub ahead of print]. [PMID: 27222587 DOI: 10.1136/postgradmedj-2016-133997] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
25 Jonaitis L, Kiudelis G, Slepavicius P, Kupcinskas L. High rate of Helicobacter pylori reinfection in Lithuanian peptic ulcer patients. World J Gastrointest Pathophysiol 2016; 7(1): 181-185 [PMID: 26909241 DOI: 10.4291/wjgp.v7.i1.181] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
26 Kim SE, Park MI, Park SJ, Moon W, Kim JH, Jung K, Seo KI, Lim SK, Jung JK, Kim HJ, Yeo GE, Jeon SC, Cho DS, Han YJ. The Influence of Iron Deficiency onHelicobacter pyloriEradication. Korean J Helicobacter Up Gastrointest Res 2016;16:82. [DOI: 10.7704/kjhugr.2016.16.2.82] [Reference Citation Analysis]
27 Kim N. Recrudescence and Reinfection After H. pylori Eradication Treatment. Helicobacter pylori 2016. [DOI: 10.1007/978-981-287-706-2_50] [Reference Citation Analysis]
28 Kim SE, Park MI, Park SJ, Moon W, Choi YJ, Cheon JH, Kwon HJ, Ku KH, Yoo CH, Kim JH. Trends in Helicobacter pylori eradication rates by first-line triple therapy and related factors in eradication therapy. Korean J Intern Med. 2015;30:801-807. [PMID: 26552455 DOI: 10.3904/kjim.2015.30.6.801] [Cited by in Crossref: 42] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
29 Kim J, Kim N, Jo HJ, Park JH, Nam RH, Seok YJ, Kim YR, Kim JS, Kim JM, Kim JM, Lee DH, Jung HC. An Appropriate Cutoff Value for Determining the Colonization of Helicobacter pylori by the Pyrosequencing Method: Comparison with Conventional Methods. Helicobacter 2015;20:370-80. [PMID: 25664664 DOI: 10.1111/hel.12214] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
30 Choi JM, Kim SG. Diagnosis and Treatment of &lt;i&gt;Helicobacter Pylori&lt;/i&gt; Infection: Korean and Overseas Guidelines. Korean J Med 2015;89:157-68. [DOI: 10.3904/kjm.2015.89.2.157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
31 Kwon YH, Kim N, Lee JY, Choi YJ, Yoon K, Hwang JJ, Lee HJ, Lee A, Jeong YS, Oh S, Yoon H, Shin CM, Park YS, Lee DH. The Diagnostic Validity of Citric Acid-Free, High Dose (13)C-Urea Breath Test After Helicobacter pylori Eradication in Korea. Helicobacter 2015;20:159-68. [PMID: 25640474 DOI: 10.1111/hel.12189] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
32 Huang YQ, Huang GR, Wu MH, Tang HY, Huang ZS, Zhou XH, Yu WQ, Su JW, Mo XQ, Chen BP, Zhao LJ, Huang XF, Wei HY, Wei LD. Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: Treatment of Helicobacter pylori-induced multidrug resistance. World J Gastroenterol 2015; 21(14): 4225-4231 [PMID: 25892872 DOI: 10.3748/wjg.v21.i14.4225] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.0] [Reference Citation Analysis]
33 Rakici H, Akdogan RA, Ayaz T, Bedir R. Is There Any Advantage of Treating Partners in Helicobacter pylori Eradication? Gastroenterol Res Pract 2015;2015:706507. [PMID: 25861262 DOI: 10.1155/2015/706507] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Kwon YH, Kim N, Lee JY, Choi YJ, Yoon K, Yoon H, Shin CM, Park YS, Lee DH. The diagnostic validity of the (13)c-urea breath test in the gastrectomized patients: single tertiary center retrospective cohort study. J Cancer Prev. 2014;19:309-317. [PMID: 25574466 DOI: 10.15430/jcp.2014.19.4.309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
35 Nam D, Kim OK, Shim TJ, Lee JK, Hwang K. Inhibitory Effects of Chios Mastic Gum on Gastric Acid Secretion by Histamine-Related Pathway in a Rat Model and Primary Parietal Cells. Journal of the Korean Society of Food Science and Nutrition 2014;43:1500-9. [DOI: 10.3746/jkfn.2014.43.10.1500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
36 Lee SY. [New guidelines for Helicobacter pylori treatment: comparisons between Korea and Japan]. Korean J Gastroenterol 2014;63:151-7. [PMID: 24651588 DOI: 10.4166/kjg.2014.63.3.151] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
37 Eusebi LH, Zagari RM, Bazzoli F. Epidemiology of Helicobacter pylori infection. Helicobacter 2014;19 Suppl 1:1-5. [PMID: 25167938 DOI: 10.1111/hel.12165] [Cited by in Crossref: 293] [Cited by in F6Publishing: 299] [Article Influence: 32.6] [Reference Citation Analysis]
38 Bruce MG, Bruden DL, Morris JM, Reasonover AL, Sacco F, Hurlburt D, Hennessy TW, Gove J, Parkinson A, Sahagun G, Davis P, Klejka J, McMahon BJ. Reinfection after successful eradication of Helicobacter pylori in three different populations in Alaska. Epidemiol Infect 2015;143:1236-46. [PMID: 25068917 DOI: 10.1017/S0950268814001770] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
39 Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC; Korean College of Helicobacter and Upper Gastrointestinal Research. [Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition]. Korean J Gastroenterol. 2013;62:3-26. [PMID: 23954956 DOI: 10.4166/kjg.2013.62.1.3] [Cited by in Crossref: 119] [Cited by in F6Publishing: 128] [Article Influence: 13.2] [Reference Citation Analysis]
40 Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, Shin WG, Shin ES, Lee YC; Korean College of Helicobacter and Upper Gastrointestinal Research. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol 2014;29:1371-86. [PMID: 24758240 DOI: 10.1111/jgh.12607] [Cited by in Crossref: 140] [Cited by in F6Publishing: 134] [Article Influence: 15.6] [Reference Citation Analysis]
41 Kim SY, Hyun JJ, Jung SW, Koo JS, Yim HJ, Lee SW. Helicobacter pylori recurrence after first- and second-line eradication therapy in Korea: the problem of recrudescence or reinfection. Helicobacter 2014;19:202-6. [PMID: 24612156 DOI: 10.1111/hel.12117] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
42 Lee SY. Current progress toward eradicating Helicobacter pylori in East Asian countries: Differences in the 2013 revised guidelines between China, Japan, and South Korea. World J Gastroenterol 2014; 20(6): 1493-1502 [PMID: 24587624 DOI: 10.3748/wjg.v20.i6.1493] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
43 Park SH, Jang JY, Dong SH, Kim HJ, Kim B, Chang YW. Successful Eradication ofHelicobacter pyloriUsing Modified Quadruple Therapy in Patient with Long-lastingH. pylori-induced Active Gastritis. Korean J Helicobacter Up Gastrointest Res 2014;14:52. [DOI: 10.7704/kjhugr.2014.14.1.52] [Reference Citation Analysis]
44 Kim MS, Kim N, Kim SE, Jo HJ, Shin CM, Park YS, Lee DH. Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy. BMC Gastroenterol. 2013;13:138. [PMID: 24050512 DOI: 10.1186/1471-230x-13-138] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
45 Cho SJ, Choi IJ, Kook MC, Yoon H, Park S, Kim CG, Lee JY, Lee JH, Ryu KW, Kim YW. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer. Aliment Pharmacol Ther 2013;38:477-89. [PMID: 23822578 DOI: 10.1111/apt.12402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]